In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
101 News Items found
A researcher working in an MSK lab
MSK Research Highlights, October 31, 2025

New MSK research uncovers unique genetic signatures in cancer patients of non-European ancestry; identifies social adversity as a potential risk factor for higher rates of triple-negative breast cancer among Black women; shows a web-based system could help head-and-neck cancer survivors report their concerns; and finds adding immunotherapy can boost the effectiveness for hard-to-treat follicular lymphomas.
Young girl
New Research Shows the HPV Cancer Vaccine Saves Lives

Learn why MSK recommends that children be vaccinated against HPV.
MSK Physician-in-Chief José Baselga presents at the ASCO meeting
Finding
Targeted Therapy Slows Growth of Most Common Type of Advanced Breast Cancer

A clinical trial provides evidence that blocking a protein called PI3K can be an effective treatment strategy for breast cancer.
Woman examining her face for signs of cancer
Feature
Five Things to Know If You've Been Diagnosed with Skin Cancer on Your Face

Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face.
A female nurse talks with a female patient, who is sitting in an exam chair
Feature
A Decade of Progress in Cancer Care, and What’s Next

Advances in diagnosis and treatment, especially those made over the past ten years, have played a significant role in the decline in cancer deaths. Learn about those advances — and what to expect in the next ten years.
DNA molecules wrapped around histones
Feature
The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.
Michael Berger, PhD, Co-Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology and Elizabeth and Felix Rohatyn Chair for Junior Faculty
Exposing a Cancer Cell’s Weakness

MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Pictured: Craig Thompson
Perspective
President Craig Thompson Reflects on 40-Year War on Cancer

Since the signing of the National Cancer Act in 1971, tremendous progress has been made in preventing and treating cancer—though challenges remain.
Marcia Levine
An Unplanned Path to Nursing Leadership at MSK

Marcia Levine didn’t grow up wanting to be a nurse. It’s a career that found her, providing a direction for the desire she always had to help, to fix things, to care for others.
An illustration
Feature
Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients

Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.